LATEST ARTICLES
CIRM approves $6 million in funding for UCI Researchers to study...
Following a California Institute for Regenerative Medicine (CIRM) Independent Citizens Oversight Committee meeting held last week, University of California, Irvine (UCI) researchers learned they...
ALBORADA Drug Discovery Institute identifies advanced Huntington’s leads using BioAscent’s Compound...
BioAscent’s unique on-demand compound library, Compound Cloud, has been used by the ALBORADA Drug Discovery Institute for virtual screening and to progress promising leads against a novel Huntington’s...
Expert-based clinical guidelines focus on behavioral symptoms in Huntington’s disease
Clinicians treating patients with HD are often not trained to recognize or treat neuropsychiatric symptoms of the disease, according to new guidelines published in...
UNIVERSITY
Study: The Brain’s Support Cells Show Defective Development in Huntington’s Disease
HUNGTINGTON'S DISEASE
The neurological disorder Huntington’s disease causes behavioural and motor changes, which among other things are a result of dysfunctional maturation or formation of...
USC scientists map brain region linked to Alzheimer’s and other diseases
Researchers show structures, nerve connections and functions in vivid detail as part of the most detailed atlas yet of a person’s memory bank
USC scientists...
Study Suggests Potential Therapy for Huntington’s Disease
A new study published in the Proceedings of the National Academy of Sciences (PNAS) suggests that Huntington’s disease may take effect much earlier in life than...
New insight into Huntington’s disease may open door to drug development
Researchers have developed a new theory on Huntington’s disease which is being welcomed for showing promise to open new avenues of drug development for...
HDBUZZ
Huntington’s disease goes viral as UniQure inches ahead in gene therapy...
FDA grants “Investigational New Drug” status to Huntingtin-lowering gene-therapy agent AMT-130, clearing path to human trials in Huntington’s Disease patients
Dutch-American company uniQure has received...
HDSA FAQ on the Roche/Genentech RG6042 program
HDSA's frequently asked questions factsheet about the huntingtin-lowering trial ASO program was so good we stole it (with permission)
n Wednesday, September 26th, HDSA hosted...
ARTICLES
IONIS-HTTRx
